Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges.

Zhu S, Liu Y, Wang PC, Gu X, Shan L. Recombinant Immunotoxin Therapy of Glioblastoma: Smart Design, Key Findings, and Specific Challenges. Biomed Res Int. 2017; 2017:7929286.

View in: PubMed

subject areas

Animals
Brain Neoplasms
Clinical Trials as Topic
Glioblastoma
Humans
Immunotoxins
Recombinant Proteins

authors with profiles

Paul Wang
Xinbin Gu

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support